Digital Health & AI
Innovation Summit

Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster patient selection for clinical trials, as well as sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine.

Infor is a global leader in business cloud software specialized by industry. We develop complete solutions for our focus industries, including life sciences, healthcare, industrial manufacturing, distribution, food & beverage, automotive, aerospace & defense, and high tech. Infor’s mission-critical enterprise applications and services are designed to deliver sustainable operational advantages with security and faster time to value. We are obsessed with delivering successful business outcomes for customers. Over 65,000 organizations in more than 175 countries rely on Infor’s 17,000 employees to help achieve their business goals. As a Koch company, our financial strength, ownership structure, and long-term view empower us to foster enduring, mutually beneficial relationships with our customers.

Dawn Health is a global leader in digital health, creating life-changing products for those living with chronic and rare diseases. Since 2016, we have designed and developed regulated digital health products across 20+ disease areas, spanning 30+ global markets, as both legal manufacturer and critical supplier. Dawn Health collaborates with pharmaceutical companies, medtech companies and health systems to deploy products that both support their strategic business objectives and improve the human experience using connected devices, digital biomarkers, GenAI and algorithms. Learn more or contact Bryan Flynn (bfl@dawnhealth.com)

OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research. We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.

At Modus Health, we accurately measure real-world walking quantity, intensity, and duration with our wearable, StepWatch, to improve treatments, therapies, and drugs. StepWatch is unique in its ability to remain accurate in patients with slow or irregular walking styles. StepWatch has been published in over 600 scientific journal articles where clinically relevant endpoints, sensitive to change, can be identified in over 40 patient conditions. With this advantage, we created specific products to fit into the flow of clinical trials, clinical care, and academic research. Our clinical trial offering includes data cleaning and 24/7 worldwide support. Our latest generation wearable, StepWatch 5, is smaller, lighter, and the most advanced StepWatch, yet. StepWatch is FDA listed and CE marked.

Alternova is a software development company completely specialized in digital health.

Alternova differentiates because of our expertise in user centered design/development of highly interactive, fun and easy to use healthcare software, specially patient facing applications, platforms, VR experiences and therapeutic and gaming inspired products. Its diverse team of visual artists and designers, game engine developers (Unity, Unreal Engine), mobile and web developers create outstanding healthcare software solutions that make patients, clinicians, researchers and care givers’ lifes easier and generate better outcomes. Takeda, Childrens National, Dana Farber, Essity, Stanford University, MIT, UCSF, UT, Brain Balance Centers and successful digital health startups such us Talkiatry are among our clients and partners.

Visionet is an engineering-led company driven by innovation. In our journey of 27+ years, we’ve helped over 350 clients across various industries to innovate faster, remain relevant, and build better products and services. With more than 8,000 people worldwide, across our 14 locations, Visionet provides transformational consulting, technology, and outsourcing services and solutions for a broad range of industries, including Retail & Consumer Goods, Pharmaceutical, Banking and Financial Institutions (BFSI), Insurance, Foods & Beverage, Manufacturing & Distribution, and Apparel & Footwear. With our alliance with global innovators, including Microsoft, Salesforce, Amazon Web Services, and Adobe, we deliver next-generation services and solutions to our clients across Cloud, Digital, Data and AI, and Business Process Management.

Learn more about Visionet at www.visionet.com

Huma Therapeutics is a global digital health company headquartered in the UK that advances digital-first care delivery and research to help people live longer, fuller lives. Huma’s award-winning modular platforms are used by more than 3,000 hospitals and clinics, with 1.8 million active users. Huma’s offering works across different disease areas and powers:

• Hospitals at Home
• Software as a Medical Device (SaMD) solutions
• Decentralized Clinical Trial (DCT) platform to support digital or hybrid studies

Huma’s platform has been shown to almost double clinical capacity, reduce readmissions by over a third, enable better diversity, participant retention and protocol adherence, whilst allowing trials to run within weeks. Please visit www.huma.com and follow us on LinkedIn at Huma

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase access to life-saving treatments. Viz.ai’s AI-powered care coordination platform is adopted by 35,000 healthcare providers across 1,300+ hospitals in the U.S. and Europe, covering more than 220 million patient lives. The Viz Platform helps to identify more patients, informs critical decisions at the point of care, and improve patient outcomes. Backed by real-world clinical evidence, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies.

Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention, and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes. Medable’s software has been named a leader in the industry by both Everest and IDC. Medable is a privately held, venture-backed company headquartered in Palo Alto, California.

BioEye has developed a proprietary eye-tracking platform which measures eye biomarkers, via a smartphone, to assess changes in brain health. Advances in smartphone technology coupled with BioEye’s sophisticated algorithms allows for brain health measurements to be quantified accurately, consistently and in real-time. Healthcare professionals have been measuring eye movements for decades to better assess patients brain health. Signals associated with the eyes are distributed across a network that includes the majority of the brain. Damage to this network manifests as measurable and stereotypical abnormalities in eye movement. The science is proven, but traditional collection methods can be subjective and inconsistent. Brain health monitoring is just the start of BioEye’s capability, which we are proudly launching through partnerships with leading sporting organisations, to improve player health. Being a smartphone based technology, the platform is both affordable and scaleable.

ZS is a management consulting and technology firm focused on transforming global healthcare and beyond. We leverage our leading-edge analytics, plus the power of data, science and products, to help our clients make more intelligent decisions, deliver innovative solutions and improve outcomes for all. Founded in 1983, ZS has more than 12,000 employees in 35 offices worldwide. To learn more, visit https://www.zs.com/ or follow us on Twitter and LinkedIn.

Medidata is reinventing global drug development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 800 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud^® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 17 of the world's top 25 global pharmaceutical companies, from study design and planning through execution, management and reporting.

Launched in 2018, xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.

Through a variety of tools and data products, xCures provides clinically actionable, real-time insights that facilitate clinical research and care for patients, providers, and partners. For more information, contact info@xcures.com.

OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together more effectively using common technology. The suite of StudyTeam solutions reduces site burden and helps sites pre-screen and enroll more patients, provides sponsors with end-to-end visibility into recruitment activity across all channels, and guides sites in conducting the trial for patients who have been enrolled. StudyTeam is trusted by the largest global biopharmaceutical companies, is used by more than 6,000 research sites, and is available in more than 100 countries. One mission. One team. That’s OneStudyTeam.

The Leaders Outlook is the ultimate platform, offering a wealth of insights on the latest trends, news, feature stories, and more on C-suite leaders, startup founders, executives, women leaders and learners. We curate insights from industry experts to navigate today’s dynamic business landscape. Our exclusive content showcases thought leadership and consultative thinking, fostering success in a disruptive ecosystem.With our pulse on the business world, we inspire the C-Suite to lead with confidence.